NICE (NICE) analyst forecast and price target
Analyst forecast
Consensus of 16 analyst ratings
Based on 5 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Oppenheimer | Upgraded | Perform → Outperform | $150.00 | Sep 30, 2026 |
| RBC Capital | Maintained | Outperform | $145.00 from $130.00 | Sep 24, 2026 |
| Rosenblatt | Maintained | Buy | $130.00 | Aug 6, 2026 |
| DA Davidson | Maintained | Buy | $115.00 from $110.00 | Aug 6, 2026 |
| Morgan Stanley | Downgraded | Overweight → Equal-Weight | $111.00 from $130.00 | Jul 21, 2026 |
| DA Davidson | Upgraded | Neutral → Buy | $110.00 | Jun 18, 2026 |
| Rosenblatt | Maintained | Buy | $155.00 | Jun 10, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $104.00 | Jun 10, 2026 |
| Wedbush | Maintained | Neutral | $100.00 from $120.00 | Jun 10, 2026 |
| RBC Capital | Maintained | Outperform | $130.00 | Jun 10, 2026 |
| Morgan Stanley | Maintained | Overweight | $130.00 from $148.00 | May 11, 2026 |
| Citigroup | Maintained | Neutral | $100.00 from $119.00 | May 8, 2026 |
| RBC Capital | Maintained | Outperform | $130.00 from $150.00 | May 7, 2026 |
| Citizens | Maintained | Market Outperform | $170.00 from $200.00 | May 7, 2026 |
| Citigroup | Downgraded | Buy → Neutral | $119.00 from $184.00 | Apr 10, 2026 |
| Rosenblatt | Maintained | Buy | $155.00 | Feb 20, 2026 |
| Wedbush | Maintained | Neutral | $120.00 | Feb 20, 2026 |
| RBC Capital | Maintained | Outperform | $150.00 from $175.00 | Feb 20, 2026 |
| Rosenblatt | Maintained | Buy | $175.00 | Dec 23, 2025 |
| Wedbush | Downgraded | Outperform → Neutral | $120.00 from $170.00 | Dec 8, 2025 |
Frequently asked questions
What is the price target for NICE stock?
The average 12-month analyst price target for NICE (NICE) is $130.20, with a high estimate of $150.00 and a low of $111.00, across 5 analysts.
Is NICE a buy, sell, or hold?
Analysts covering NICE currently average a Buy rating: 8 buy, 8 hold and 0 sell, from 16 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for NICE?
The average price target of $130.20 implies 17.30% upside from the last price of $111.00.
What is the latest analyst rating on NICE?
On Sep 30, 2026, Oppenheimer upgraded NICE to Outperform with a price target of $150.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.